Current research on cardiovascular complications of novel coronavirus pneumonia
CSTR:
Author:
Affiliation:

1.Department of Cardiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430000, China;2.Department of Cardiology, the Third People’s Hospital of Hubei Provinence, Wuhan, Hubei 430032, China;3.Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, China)

Clc Number:

R541

  • Article
  • | |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • | |
  • Comments
    Abstract:

    The novel coronavirus pneumonia, also known as the coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The current clinical evidence shows that the risk of death is significantly increased in patients with COVID-19 combined with underlying cardiovascular diseases. Most patients will develop myocarditis, myocardial injury, arrhythmia and cardiomyopathy in the course of the disease. This article mainly describes the current research situation of cardiovascular complications of COVID-19.

    Reference
    Related
    Cited by
Get Citation

Lü Chao, QIN Yating, RUAN Weibing, CHEN Chen, LU Li, GUO Xiaomei. Current research on cardiovascular complications of novel coronavirus pneumonia[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2021,29(12):1081-1084.

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:May 21,2020
  • Revised:March 21,2021
  • Online: November 24,2021
Article QR Code